Metsera

Troy, New Hampshire, United States, 10007

Company profile

Metsera company profile

Metsera is a biotechnology company that develops and manufactures therapies. The company's focus is on nutrient-stimulated hormone therapies for obesity and related conditions. Its portfolio includes both injectable and oral therapeutic candidates.

Business identity

Website: https://metsera.com
Phone number: +1 212 784-6595
Operating status: Active
Company type: For Profit
Employee range: 51-100 employees
Revenue range: $10M-$100M
Founded: 2022-01-01, Year

LinkedIn X

Headquarters

Headquarters: Troy, New Hampshire, United States
Postal code: 10007
Country code: US
Continent: North America

Capital profile

Funding and company signals

Funding stage: M And A
Funding rounds: 3
Total equity funding: $505M
Last funding: Series B / $215M / 2024-11-13
Last equity funding: Series B / $215M
Investors: 17
Lead investors: 4
Founders: 1
Articles: 775
Exited on: 2025-01-31

Categories and groups

Biopharma Health Care Medical Pharmaceutical Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Whit Bernard

Lead investors

ARCH Venture PartnersPopulation Health PartnersVenrock Healthcare Capital PartnersWellington Management

Investors

ARCH Venture PartnersFidelityJanus Henderson InvestorsRA Capital ManagementWellington Management